Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revvity (RVTY)
NYSE:RVTY
RVTY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$97.32 - $129.50
Previous CloseN/A
Volume176.09K
Average Volume (3M)958.63K
Market Cap
$13.96B
Enterprise Value$15.75B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)49.8
Beta0.89
Next Earnings
May 06, 2025EPS Estimate
0.95Next Dividend Ex-Date
Apr 17, 2025Dividend Yield0.24%
Share Statistics
EPS (TTM)2.35
Shares Outstanding121,702,150
10 Day Avg. Volume997,976
30 Day Avg. Volume958,633
Standard Deviation0.10
R-Squared0.32
Alpha-0.00238
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.14
Price to Cash Flow (P/CF)23.70
P/FCF Ratio27.90
Enterprise Value/Market Cap1.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.25
Enterprise Value/Ebitda20.99
Forecast
1Y Price Target
$136.38Price Target Upside19.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevvity's core recurring revenue businesses, which make up over 80% of sales, are showing positive signals, including an increase in reagents and ImmunoDx.
Market ReactionThe stock is indicated to rise about 4% following the update, reflecting a positive market reaction.
Bears Say
Market ConcernsInvestors are concerned about potential headwinds from China's volume-based procurement and slower recovery in the core business.
---
Ownership Overview
0.37% Insiders
35.12% Mutual Funds
31.90% Other Institutional Investors
8.75% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RVTY FAQ
What was Revvity’s price range in the past 12 months?
Revvity lowest stock price was $97.31 and its highest was $129.50 in the past 12 months.
What is Revvity’s market cap?
Revvity’s market cap is $13.96B.
When is Revvity’s upcoming earnings report date?
Revvity’s upcoming earnings report date is May 06, 2025 which is in 73 days.
How were Revvity’s earnings last quarter?
Revvity released its earnings results on Jan 31, 2025. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.368 by $0.052.
Is Revvity overvalued?
According to Wall Street analysts Revvity’s price is currently Undervalued.
Does Revvity pay dividends?
Revvity pays a Quarterly dividend of $0.28 which represents an annual dividend yield of 0.24%. See more information on Revvity dividends here
What is Revvity’s EPS estimate?
Revvity’s EPS estimate is 0.95.
How many shares outstanding does Revvity have?
Revvity has 121,702,150 shares outstanding.
What happened to Revvity’s price movement after its last earnings report?
Revvity reported an EPS of $1.42 in its last earnings report, beating expectations of $1.368. Following the earnings report the stock price went down -0.56%.
Which hedge fund is a major shareholder of Revvity?
Currently, no hedge funds are holding shares in RVTY
---
Revvity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$136.38 (19.80% Upside)
$136.38 (19.80% Upside)
Blogger Sentiment
Bullish
RVTY Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $235.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.6%
Last 30 Days ▲ 17.0%
Last 30 Days ▲ 17.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.77%
12-Months-Change
Fundamentals
Return on Equity
3.72%
Trailing 12-Months
Asset Growth
-8.64%
Trailing 12-Months
Company Description
Revvity
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
---
RVTY Company Deck
---
RVTY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Revvity demonstrated strong performance in the fourth quarter, particularly in its Life Sciences reagents, software, and diagnostics segments. The company achieved impressive cash flow and continued strategic investments. However, challenges remain in the instrumentation business, and FX headwinds and market uncertainties present potential risks.Read More>---
RVTY Revenue Breakdown
53.02% Diagnostics
46.98% Life sciences
---
RVTY Stock 12 Month Forecast
Average Price Target
$136.38
▲(19.80% Upside)
Technical Analysis
Best Analysts Covering RVTY
1 Year
1 Year Success Rate
19/32 ratings generated profit
1 Year Average Return
+9.78%
reiterated a buy rating 20 days ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 59.38% of your transactions generating a profit, with an average return of +9.78% per trade.
---